Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
55.74
+3.22 (6.13%)
At close: Mar 9, 2026, 4:00 PM EDT
55.69
-0.05 (-0.09%)
After-hours: Mar 9, 2026, 7:15 PM EDT
Moderna Employees
Moderna had 4,700 employees as of December 31, 2025. The number of employees decreased by 1,100 or -18.97% compared to the previous year.
Employees
4,700
Change (1Y)
-1,100
Growth (1Y)
-18.97%
Revenue / Employee
$413,617
Profits / Employee
-$600,426
Market Cap
22.01B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4,700 | -1,100 | -18.97% |
| Dec 31, 2024 | 5,800 | 200 | 3.57% |
| Dec 31, 2023 | 5,600 | 1,700 | 43.59% |
| Dec 31, 2022 | 3,900 | 1,200 | 44.44% |
| Dec 31, 2021 | 2,700 | 1,400 | 107.69% |
| Dec 31, 2020 | 1,300 | 470 | 56.63% |
| Dec 31, 2019 | 830 | 70 | 9.21% |
| Dec 31, 2018 | 760 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 6,772 |
| Genmab | 2,973 |
| Incyte | 2,844 |
| Insmed | 1,664 |
| Ionis Pharmaceuticals | 1,402 |
| Ascendis Pharma | 1,189 |
| Revolution Medicines | 883 |
MRNA News
- 5 hours ago - What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday? - Benzinga
- 3 days ago - FDA reversals leave investors worrying about the fates of other experimental drugs - CNBC
- 5 days ago - The Sun Will Shine On Moderna Again - Initiating With A Buy - Seeking Alpha
- 5 days ago - Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom - Seeking Alpha
- 5 days ago - Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang - Reuters
- 5 days ago - Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars - Benzinga
- 5 days ago - Moderna Stock Rallies. This Big Risk Just Got Eliminated. - Barrons
- 6 days ago - Moderna's stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline - Market Watch